Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)

Closed Posted

Opportunity number
PAR-24-297
Agency
Applications due
Award size
Up to $150,000

Opportunity facts

Assistance listings
Funding instrument
Grant
Categories
  • Education
  • Health
Eligible applicants
  • Non-501(c)(3) Nonprofits
  • City/Township Governments
  • Higher Education Inst. (Private)
  • Special District Governments
  • Higher Education Inst. (Public)
  • For Profit Organizations
  • Small Businesses
  • County Governments
  • State Governments
  • Public or Indian Housing Auth.
  • 501(c)(3) Nonprofits
  • Tribal Organizations (Not Federally Recognized)
  • Independent School Districts
  • Tribal Governments (Federally Recognized)
  • Other
Points of contact
Full announcement

Opportunity details come from Grants.gov. Updated .

About this opportunity

The National Institutes of Health is soliciting applications for the Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) to fund brain imaging research on substance use disorders and addiction, with an application due date of July 29, 2026.

This R03 grant mechanism supports newly independent investigators and established investigators developing or adopting neuroimaging tools and methodologies through small proof-of-concept studies. Eligible applicants include small businesses, tribal governments (federally and non-federally recognized), nonprofits (including 501(c)(3) organizations), public and private higher education institutions, for-profit organizations, state and local governments, public housing authorities, and independent school districts. Foreign components are eligible per NOT-DA-24-060. The program funds projects designed to be completed in a short period with limited resources.

Awards are made under the Drug Use and Addiction Research Programs (CFDA 93.279). The R03 mechanism typically supports discrete, time-limited research projects with budgets substantially lower than standard R01 research grants. NIH review encompasses scientific and technical merit, research feasibility, potential contribution to addressing the national drug abuse problem, and alignment with NIDA priorities. The standard NIH peer review cycle runs 240 to 270 days from submission.

Applicants may pursue either a basic science track or a clinical trial optional track. This NOFO was originally posted November 1, 2024, and close date was updated to align with reissued NOFO PAS-27-028. Award ceiling, number of awards, period of performance, and cost share requirements are not specified in the source material.

Synopsis

2 versions

Update #2 · Latest ·

This Notice of Funding Opportunity Announcement (NOFO) is designed to encourage and facilitate the entry of investigators to the area of brain imaging research. This NOFO will support both newly independent investigators and established investigators who are seeking to develop and adopt neuroimaging tools and methodologies in their research programs and conduct small "proof-of-concept" studies relevant to substance use disorders and addiction. This NOFO is intended to support Small Research Grant (R03) projects that can be carried out in a short period of time with limited resources.

Update #1 ·

This Notice of Funding Opportunity Announcement (NOFO) is designed to encourage and facilitate the entry of investigators to the area of brain imaging research. This NOFO will support both newly independent investigators and established investigators who are seeking to develop and adopt neuroimaging tools and methodologies in their research programs and conduct small "proof-of-concept" studies relevant to substance use disorders and addiction. This NOFO is intended to support Small Research Grant (R03) projects that can be carried out in a short period of time with limited resources.

Files

File Type Posted
PAR-24-297-Full-Announcement.html HTML file

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar grant opportunities
  • Ask GovTribe AI about this opportunity